---
title: "3-Methylamino-1,2-Propanediol Market, Global Outlook and Forecast 2025-2032"
datePublished: Sun Oct 12 2025 22:00:37 GMT+0000 (Coordinated Universal Time)
cuid: cmgo903vn000102ld0wx90vwj
slug: 3-methylamino-12-propanediol-market-global-outlook-and-forecast-2025-2032

---

# 3-Methylamino-1,2-Propanediol Market, Global Outlook and Forecast 2025-2032

<p><strong>MARKET INSIGHTS</strong></p><p>
</p><p>Global 3-Methylamino-1,2-Propanediol market size was valued at <strong>USD 52.5 million in 2024</strong> and is projected to reach <strong>USD 75.9 million by 2032</strong>, growing at a <strong>CAGR of 5.5%</strong>during the forecast period.</p><div><b>Download FREE Sample of this Report @ 
            <a href="https://www.24chemicalresearch.com/download-sample/296202/3-methylamino-1-2-propanediol-market">
            https://www.24chemicalresearch.com/download-sample/296202/3-methylamino-1-2-propanediol-market</a></b></div><br><p>
</p><p>3-Methylamino-1,2-Propanediol (CAS 40137-22-2) is an organic compound with the molecular formula C4H11NO2. Primarily used as an intermediate in the synthesis of non-ionic X-CT contrast agents like iopromide, this versatile chemical has gained prominence across pharmaceutical, cosmetic, and industrial applications. Its ability to regulate pH levels makes it particularly valuable in skincare formulations, while its role as a building block for specialty chemicals drives demand in industrial sectors.</p><p>
</p><p>The market growth is fueled by increasing diagnostic imaging procedures requiring contrast agents, coupled with expanding applications in personal care products. However, stringent regulatory requirements for pharmaceutical-grade materials pose challenges for manufacturers. Key players such as Borregaard and Daicel are focusing on production capacity expansions to meet the growing demand, particularly from Asia-Pacific markets where healthcare infrastructure development is accelerating.</p><p>
<strong>MARKET DYNAMICS</strong></p><p>
<strong>MARKET DRIVERS</strong></p><p>
</p><p style="text-align:center"><strong>Growing Demand for Contrast Media in Medical Imaging to Propel Market Growth</strong></p><p>
</p><p>The exponential growth in diagnostic imaging procedures globally is driving significant demand for <strong>3-Methylamino-1,2-Propanediol </strong>as a key intermediate in contrast media production. With medical imaging volumes projected to grow at 5.3% annually through 2030, the need for high-quality contrast agents has never been greater. X-ray contrast media containing iopromide, where 3-Methylamino-1,2-Propanediol serves as a crucial building block, accounted for approximately 38% of all contrast media used in radiology departments worldwide in 2023. This expanding application in healthcare diagnostics creates a robust foundation for market expansion.</p><p>
</p><p style="text-align:center"><strong>Pharmaceutical Industry Expansion to Accelerate Consumption</strong></p><p>
</p><p>The global pharmaceutical market, valued at $1.6 trillion in 2024, continues its upward trajectory with a projected 6.2% CAGR through 2030. As pharmaceutical manufacturers seek more sophisticated intermediates for drug synthesis, 3-Methylamino-1,2-Propanediol has emerged as a valuable chiral building block. Its unique molecular structure enables the synthesis of complex active pharmaceutical ingredients (APIs), particularly in neurological and cardiovascular therapeutics. The compound's versatility in pharmaceutical applications positions it for sustained demand growth as the industry pushes for more effective and targeted medications.</p><p>
</p><p>Regulatory approvals for new contrast media formulations containing derivatives of 3-Methylamino-1,2-Propanediol further reinforce market prospects. Recent approvals in major markets have demonstrated the compound's safety profile and efficacy in medical applications, encouraging broader adoption.</p><p>
<strong>MARKET RESTRAINTS</strong></p><p>
</p><p style="text-align:center"><strong>Stringent Regulatory Requirements to Limit Market Penetration</strong></p><p>
</p><p>The pharmaceutical-grade production of 3-Methylamino-1,2-Propanediol faces significant regulatory hurdles that constrain market expansion. Compliance with Good Manufacturing Practice (GMP) standards requires substantial capital investment, with facility certification costs often exceeding $2 million for medium-scale producers. These rigorous quality control measures, while necessary for medical applications, create barriers to entry for smaller manufacturers and potentially limit supply diversification in the market.</p><p>
</p><p>Current regulatory evaluations of contrast media safety profiles are becoming increasingly stringent, potentially extending the approval timeline for new formulations by 18-24 months compared to a decade ago. This prolonged approval process may temporarily slow market adoption of innovative applications for 3-Methylamino-1,2-Propanediol in advanced medical imaging technologies.</p><p>
<strong>MARKET CHALLENGES</strong></p><p>
</p><p style="text-align:center"><strong>Supply Chain Vulnerabilities to Impact Market Stability</strong></p><p>
</p><p>The specialized production of high-purity 3-Methylamino-1,2-Propanediol presents distinct supply chain challenges. With over 65% of global production capacity concentrated in just three countries, the market remains vulnerable to geopolitical disruptions and trade policy changes. Recent logistics bottlenecks have demonstrated how regional production concentrations can lead to 30-45 day delivery delays, creating costly discontinuities for end-users in the pharmaceutical and medical imaging sectors.</p><p>
</p><p>Raw material procurement presents another critical challenge, as several precursor chemicals required for synthesis face periodic shortages. These upstream supply constraints can unexpectedly increase production lead times by 50% or more, forcing manufacturers to maintain higher inventory levels and increasing working capital requirements.</p><p>
<strong>MARKET OPPORTUNITIES</strong></p><p>
</p><p style="text-align:center"><strong>Emerging Applications in Advanced Therapeutics to Open New Growth Avenues</strong></p><p>
</p><p>The compound's potential in next-generation drug delivery systems represents a promising growth frontier. Recent research indicates that 3-Methylamino-1,2-Propanediol derivatives could enhance the stability and bioavailability of peptide-based therapeutics, a market segment projected to exceed $75 billion by 2030. Pharmaceutical companies are increasingly exploring these applications, with five major industry players having initiated preclinical studies using the compound as a key excipient in novel formulations.</p><p>
</p><p>Technological advancements in production processes are creating additional opportunities. Continuous flow chemistry methods have demonstrated potential to increase yields by 25-30% while reducing solvent use by 40%, offering both economic and environmental benefits. Early adopters of these innovative manufacturing techniques stand to gain significant competitive advantage in high-growth market segments.</p><p>
<strong>MARKET TRENDS</strong></p><p>
<strong>Pharmaceutical Applications Drive Growth in the 3-Methylamino-1,2-Propanediol Market</strong></p><p>
</p><p>Global <strong>3-Methylamino-1,2-Propanediol market</strong>, valued at <strong>$52.5 million in 2024</strong>, is projected to reach <strong>$75.9 million by 2032</strong>, growing at a <strong>CAGR of 5.5%</strong> during the forecast period. One of the primary growth drivers is its critical role as an intermediate in contrast media formulations for medical imaging. With the rising prevalence of chronic diseases necessitating diagnostic imaging, demand for high-purity batches of 3-Methylamino-1,2-Propanediol—especially in the <strong>99% purity segment</strong>—has surged. This aligns with the pharmaceutical industry's stringent quality standards, ensuring stability and efficacy in contrast agents. Furthermore, the expansion of <strong>specialty chemicals manufacturing</strong>, supported by increased healthcare investments, reinforces this upward trajectory.</p><p>
<strong>Other Trends</strong></p><p>
</p><p style="text-align:center"><strong>Cosmetic Industry Adoption for pH Regulation</strong></p><p>
</p><p>Beyond pharmaceuticals, the cosmetic industry has emerged as a key consumer of 3-Methylamino-1,2-Propanediol due to its <strong>pH-stabilizing properties</strong>. As skincare brands prioritize mild yet effective formulations, this compound is increasingly used in <strong>moisturizers, serums, and cleansers</strong>. The global cosmetics market, projected to exceed $850 billion by 2030, underscores the potential for sustained demand growth. Additionally, regulatory shifts toward safer, non-toxic ingredients in regions like Europe and North America further position 3-Methylamino-1,2-Propanediol as a preferred additive, particularly in products targeting sensitive skin.</p><p>
<strong>Supply Chain Resilience and Regional Market Dynamics</strong></p><p>
</p><p>Geopolitical factors and supply chain optimization are reshaping the market landscape. <strong>Asia-Pacific dominates production</strong>, accounting for over 60% of global capacity, driven by cost-effective manufacturing hubs in China and India. However, recent trade disruptions have prompted <strong>diversification strategies</strong>, with European and North American suppliers expanding local production to mitigate risks. Meanwhile, advancements in <strong>green chemistry</strong> are influencing procurement, as manufacturers seek sustainable alternatives to traditional synthesis methods. This shift aligns with global ESG (Environmental, Social, and Governance) goals, creating opportunities for innovators in the sector.</p><p>
<strong>COMPETITIVE LANDSCAPE</strong></p><p>
<strong>Key Industry Players</strong></p><p>
</p><p style="text-align:center"><strong>Market Leaders Drive Innovation in Specialty Chemical Applications</strong></p><p>
</p><p>Global 3-Methylamino-1,2-Propanediol market features a <strong>moderately fragmented</strong> competitive environment, with key players competing through technological advancements and strategic supply chain expansions. <strong>Borregaard</strong> emerges as a dominant force, leveraging its expertise in bio-based chemicals and strong European distribution network. The company has consistently invested in production optimization, allowing it to maintain approximately <strong>22% market share</strong> in 2024.</p><p>
</p><p>Meanwhile, <strong>Daicel Corporation</strong> has demonstrated remarkable growth in the APAC region, particularly through its pharmaceutical-grade 3-Methylamino-1,2-Propanediol offerings. The company's recent capacity expansion in Japan positions it favorably to meet the growing demand from contrast media manufacturers. Similarly, <strong>Yangzhou Princechem</strong> has strengthened its position through cost-competitive production and aggressive pricing strategies.</p><p>
</p><p>Chinese manufacturers like <strong>Inner Mongolia Saintchem Chemicals</strong> are gaining traction through government-supported chemical industry initiatives. While these regional players currently focus on domestic markets, their increasing export activities—particularly in Southeast Asia—are reshaping global supply dynamics. The company's recent 15,000-ton capacity addition demonstrates this expansion strategy.</p><p>
</p><p>All major competitors are prioritizing <strong>R&amp;D collaborations</strong> with end-users, particularly in developing high-purity (99%+) variants for medical applications. Several announced joint ventures between chemical manufacturers and radiopharmaceutical companies suggest this trend will intensify through 2030, potentially altering current market share distributions.</p><p>
<strong>List of Key 3-Methylamino-1,2-Propanediol Producers</strong></p><p>
</p><p><strong>Borregaard (Norway)</strong></p><p>Daicel Corporation (Japan)</p><p>Inner Mongolia Saintchem Chemicals (China)</p><p>Yangzhou Princechem (China)</p><p>Tokyo Chemical Industry Co., Ltd. (Japan)</p><p>Hubei Norna Technology Co., Ltd (China)</p><p>Haihang Industry Co., Ltd. (China)</p><p>Merck KGaA (Germany)</p><p>
<strong>Segment Analysis</strong></p><p>
<strong>By Type</strong></p><p>
</p><p><strong>Purity 99% Segment Holds Significant Market Share Due to High Pharmacopeia Compliance Standards</strong></p><p>
</p><p>The market is segmented based on type into:</p><p>
</p><p>Purity 98%</p><p>Purity 99%</p><p>Others</p><p>
<strong>By Application</strong></p><p>
</p><p><strong>Contrast Medium Intermediates Segment Leads Market Owing to Increasing Demand for Diagnostic Imaging Agents</strong></p><p>
</p><p>The market is segmented based on application into:</p><p>
</p><p>Contrast Medium Intermediates</p><p>Chemical Reagent</p><p>Others</p><p>
<strong>By End User</strong></p><p>
</p><p><strong>Pharmaceutical Industry Accounts for Largest Share Due to Critical Role in Drug Formulations</strong></p><p>
</p><p>The market is segmented based on end user into:</p><p>
</p><p>Pharmaceutical Companies</p><p>Chemical Manufacturers</p><p>Research Institutions</p><p>Others</p><p>
<strong>By Region</strong></p><p>
</p><p><strong>Asia Pacific Emerges as Fastest Growing Market Driven by Expanding Pharmaceutical Production</strong></p><p>
</p><p>The market is segmented based on region into:</p><p>
</p><p>North America</p><p>Europe</p><p>Asia Pacific</p><p>Latin America</p><p>Middle East &amp; Africa</p><p>
<strong>Regional Analysis: 3-Methylamino-1,2-Propanediol Market</strong></p><p>
</p><p><strong>North America</strong></p><p>
</p><p>The North American 3-Methylamino-1,2-Propanediol market is primarily driven by the booming pharmaceutical sector, particularly the demand for contrast medium intermediates used in diagnostic imaging. The U.S. accounts for approximately 65% of the regional market share due to its advanced healthcare infrastructure and strong R&amp;D investments. Regulatory compliance with FDA standards and increasing applications in specialty chemicals further bolster growth. However, supply chain complexities and high production costs pose challenges for manufacturers. Companies like Borregaard are expanding production capacity to meet the rising demand, particularly for high-purity (99%) grades used in pharmaceutical synthesis.</p><p>
</p><p><strong>Europe</strong></p><p>
</p><p>Europe’s market is characterized by stringent REACH regulations and a focus on sustainable chemical manufacturing. Germany leads in consumption, given its robust pharmaceutical and cosmetic industries, which utilize 3-Methylamino-1,2-Propanediol for pH regulation and drug intermediates. The region is witnessing a shift toward bio-based alternatives, pressuring suppliers to innovate. Despite this, demand remains steady, supported by aging populations requiring diagnostic imaging. Daicel and other key players are investing in eco-friendly production methods to align with the EU’s Green Deal initiatives, though high operational costs limit smaller competitors.</p><p>
</p><p><strong>Asia-Pacific</strong></p><p>
</p><p>As the fastest-growing market, Asia-Pacific dominates global consumption, led by China and India. The region's cost-effective manufacturing and expanding pharmaceutical sectors drive demand, particularly for purity 98% grades. China’s iopromide contrast agent production relies heavily on 3-Methylamino-1,2-Propanediol, with local players like Yangzhou Princechem capturing over 30% of regional sales. However, price sensitivity and inconsistent regulatory enforcement create volatility. India’s burgeoning generic drug industry is also contributing to growth, though infrastructure gaps delay large-scale adoption.</p><p>
</p><p><strong>South America</strong></p><p>
</p><p>The South American market remains nascent but promising, with Brazil and Argentina leading demand for pharmaceutical intermediates. Economic instability and import dependency hinder consistent growth, as most raw materials are sourced from Asia. However, government initiatives to strengthen local API production could unlock opportunities. The cosmetics sector is emerging as a niche application area, leveraging the compound’s pH-stabilizing properties. Still, limited technological advancement and currency fluctuations deter major investments.</p><p>
</p><p><strong>Middle East &amp; Africa</strong></p><p>
</p><p>This region shows moderate growth, driven by healthcare modernization in GCC countries like Saudi Arabia and the UAE. The lack of local manufacturing forces reliance on imports, primarily from Europe and Asia. Turkey’s pharmaceutical industry is a notable adopter, but regulatory hurdles and low industrial penetration slow broader uptake. Long-term potential lies in diversification efforts to reduce oil dependency, with chemical and cosmetic applications gaining traction. Nonetheless, infrastructure deficits and political instability in some areas curb rapid expansion.</p><p>
<strong>Report Scope</strong></p><p>
</p><p>This report presents a comprehensive analysis of the global and regional markets for 3-Methylamino-1,2-Propanediol, covering the period from 2024 to 2032. It includes detailed insights into the current market status and outlook across various regions and countries, with specific focus on:</p><p>
</p><p><strong>Sales, sales volume, and revenue forecasts</strong></p><p><strong>Detailed segmentation by type and application</strong></p><p>
</p><p>In addition, the report offers in-depth profiles of key industry players, including:</p><p>
</p><p>Company profiles</p><p>Product specifications</p><p>Production capacity and sales</p><p>Revenue, pricing, gross margins</p><p>Sales performance</p><p>
</p><p>It further examines the competitive landscape, highlighting the major vendors and identifying the critical factors expected to challenge market growth.</p><p>
</p><p>As part of this research, we surveyed 3-Methylamino-1,2-Propanediol manufacturers, suppliers, distributors, and industry experts. The survey covered various aspects, including:</p><p>
</p><p>Revenue and demand trends</p><p>Product types and recent developments</p><p>Strategic plans and market drivers</p><p>Industry challenges, obstacles, and potential risks</p><p>
<strong>FREQUENTLY ASKED QUESTIONS:</strong></p><p>
<strong>What is the current market size of Global 3-Methylamino-1,2-Propanediol Market?</strong></p><p>
</p><p>-&gt; Global 3-Methylamino-1,2-Propanediol market was valued at USD 52.5 million in 2024 and is projected to reach USD 75.9 million by 2032, growing at a CAGR of 5.5% during the forecast period.</p><p>
<strong>Which key companies operate in Global 3-Methylamino-1,2-Propanediol Market?</strong></p><p>
</p><p>-&gt; Key players include Borregaard, Inner Mongolia Saintchem Chemicals, Daicel, and Yangzhou Princechem, among others.</p><p>
<strong>What are the key growth drivers?</strong></p><p>
</p><p>-&gt; Key growth drivers include increasing demand for contrast medium intermediates, expansion of pharmaceutical applications, and rising adoption in cosmetic formulations.</p><p>
<strong>Which region dominates the market?</strong></p><p>
</p><p>-&gt; Asia-Pacific is the fastest-growing market, driven by China's pharmaceutical manufacturing growth, while Europe leads in production capacity.</p><p>
<strong>What are the emerging trends?</strong></p><p>
</p><p>-&gt; Emerging trends include development of high-purity grades (99%+), increasing R&amp;D investments for new applications, and sustainable production methods.</p>

<div><b>Get the Complete Report & TOC @ 
            <a href="https://www.24chemicalresearch.com/reports/296202/3-methylamino-1-2-propanediol-market">
            https://www.24chemicalresearch.com/reports/296202/3-methylamino-1-2-propanediol-market</a></b></div><br>
            <b>Table of Content:</b><p>1 Introduction to Research & Analysis Reports<br />
 1.1 3-Methylamino-1,2-Propanediol Market Definition<br />
 1.2 Market Segments<br />
 1.2.1 Segment by Type<br />
 1.2.2 Segment by Application<br />
 1.3 Global 3-Methylamino-1,2-Propanediol Market Overview<br />
 1.4 Features & Benefits of This Report<br />
 1.5 Methodology & Sources of Information<br />
 1.5.1 Research Methodology<br />
 1.5.2 Research Process<br />
 1.5.3 Base Year<br />
 1.5.4 Report Assumptions & Caveats<br />
2 Global 3-Methylamino-1,2-Propanediol Overall Market Size<br />
 2.1 Global 3-Methylamino-1,2-Propanediol Market Size: 2024 VS 2032<br />
 2.2 Global 3-Methylamino-1,2-Propanediol Market Size, Prospects & Forecasts: 2020-2032<br />
 2.3 Global 3-Methylamino-1,2-Propanediol Sales: 2020-2032<br />
3 Company Landscape<br />
 3.1 Top 3-Methylamino-1,2-Propanediol Players in Global Market<br />
 3.2 Top Global 3-Methylamino-1,2-Propanediol Companies Ranked by Revenue<br />
 3.3 Global 3-Methylamino-1,2-Propanediol Revenue by Companies<br />
 3.4 Global 3-Methylamino-1,2-Propanediol Sales by Companies<br />
 3.5 Global 3-Methylamino-1,2-Propanediol Price by Manufacturer (2020-2025)<br />
 3.6 Top 3 and Top 5 3-Methylamino-1,2-Propanediol Companies in Global Market, by Revenue in 2024<br />
 3.7 Global Manufacturers 3-Methylamino-1,2-Propanediol Product Type<br />
 3.8 Tier 1, Tier 2, and Tier 3 3-Methylamino-1,2-Propanediol Players in Global Market<br />
 3.8.1 List of Global Tier 1 3-Methylamino-1,2-Propanediol Companies<br />
 3.8.2 List of Global Tier 2 and Tier 3 3-Methylamino-1,2-Propanediol Companies<br />
4 Sights by Product<br />
 4.1 Overview<br />
 4.1.1 Segmen</p>

<div><b>Get the Complete Report & TOC @ 
            <a href="https://www.24chemicalresearch.com/reports/296202/3-methylamino-1-2-propanediol-market">
            https://www.24chemicalresearch.com/reports/296202/3-methylamino-1-2-propanediol-market</a></b></div><br>

<b>CONTACT US:</b><br>
            203A, City Vista, Fountain Road, Kharadi, Pune, India - 411014<br>
            International: +1(332) 2424 294<br>
            Asia: +91 9169162030 <br><br>
            Follow Us On LinkedIn: <a href="https://www.linkedin.com/company/24chemicalresearch/">24ChemicalResearch LinkedIn</a>